Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib

Thyroid. 2008 Aug;18(8):911-4. doi: 10.1089/thy.2007.0325.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Celecoxib
  • Color Perception / drug effects
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Female
  • Graves Ophthalmopathy / drug therapy*
  • Humans
  • Prednisone / adverse effects
  • Pyrazoles / therapeutic use*
  • Sulfonamides / therapeutic use*
  • Visual Acuity / drug effects

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib
  • Prednisone